FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Teva Pharmaceuticals' supplemental application for amlodipine besylate under ANDA 076846.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Hypertension

Drugs mentioned

• Amlodipine besylate (amlodipine besylate)

Snippet

SUPPL AP for AMLODIPINE BESYLATE (AMLODIPINE BESYLATE)